Drugdiscovery >> Drugs >> News
6450
Views
title
Nizoral (ketoconazole) warning - drugdiscovery.com


FDA has limited Nizoral oral tablets use due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems.
Read More >>


Tags: Nizoral, ketoconazole, liver injury, drug interactions, drug safety, adrenal gland problems - August 4, 2013
Related Articles
3352
Views
Death warning for Pfizer's antibiotic Tygacil Death warning for Pfizer's antibiotic Tygacil
The intravenous antibiotic Tygacil (tigecycline) is approved as a treatment for complicated skin and skin structure infections and community-acquired bacterial pneumonia. The FDA decided to add a boxe Read More >>

Tags: Tygacil, tigecycline, antibiotic, death warning, warning, FDA, label, Pfizer

4365
Views
Rituxan and Arzerra get a boxed warning of HBV risk Rituxan and Arzerra get a boxed warning of HBV risk
The anti-CD20-directed monoclonal antibodies used to treat chronic lymphocytic leukemia, rituximab (Rituxan) and ofatumumab (Arzerra), will from now carry a boxed warning of the risk for immunosuppres Read More >>

Tags: Rituxan, Arzerra, warning, HBV, risk

3133
Views
Plavix Warning Plavix Warning
Latest research shows that prolonged use (for more than a year) of a blood thinner Plavix by patients after they have received artery-opening stents can lead to fatal bleeding. A consumer advocacy gro Read More >>

Tags: plavix, blood thinner, prolonged use, artery-opening stents, stent, risk, bleeding

3555
Views
Red warning soon on Tylenol Red warning soon on Tylenol
Johnson & Johnson will add red warning on the cap of each new bottle of Extra Strength Tylenol sold in the U.S. The aim is to alert users of potentially fatal risks of taking too much of this pain rel Read More >>

Tags: Johnson & Johnson, Tylenol, tylenol, risks, pain reliever, acetaminophen, liver failure

4611
Views
Celgene’s cancer drug Imnovid may cause birth defects Celgene’s cancer drug Imnovid may cause birth defects
Imnovid (pomalidomide) has recently been approved in Europe for the treatment of adult patients with relapsed and refractory multiple myeloma (MM). Recent observations in animal models suggest that th Read More >>

Tags: imnovid, pomalidomide, teratogenic effect, multiple myeloma, warning, birth defects

3182
Views
The FDA warns about Ortiga supplement The FDA warns about Ortiga supplement
Ortiga is unapproved product promoted for a range of health conditions and sold on multiple websites. FDA analysis confirmed that Ortiga contains diclofenac, a prescription non-steroidal anti-inflamma Read More >>

Tags: ortiga, ortiga supplement, FDA warning, diclofenac, non-steroidal anti-inflammatory

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013